i-Factor (TM) Bone Graft vs Autograft in Anterior Cervical Discectomy and Fusion: 2-Year Follow-up of the Randomized Single-Blinded Food and Drug Administration Investigational Device Exemption Study COMMENT

Riew K. Daniel

首页> 外文期刊>Neurosurgery >i-Factor (TM) Bone Graft vs Autograft in Anterior Cervical Discectomy and Fusion: 2-Year Follow-up of the Randomized Single-Blinded Food and Drug Administration Investigational Device Exemption Study COMMENT

【24h】

i-Factor (TM) Bone Graft vs Autograft in Anterior Cervical Discectomy and Fusion: 2-Year Follow-up of the Randomized Single-Blinded Food and Drug Administration Investigational Device Exemption Study COMMENT

机译：I-Faction（TM）骨移植与颈椎切除术和融合中的自体移植：随机单盲食品和药物管理局的2年后续随访调查装置豁免研究评论

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Neurosurgery 》 |2018年第3期| 共1页
作者
Riew K. Daniel;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类头部及神经外科学 ;
关键词

相似文献

外文文献
中文文献
专利

1. i-Factor (TM) Bone Graft vs Autograft in Anterior Cervical Discectomy and Fusion: 2-Year Follow-up of the Randomized Single-Blinded Food and Drug Administration Investigational Device Exemption Study COMMENT [J] . Riew K. Daniel Neurosurgery . 2018 ,第3期

机译：I-Faction（TM）骨移植与颈椎切除术和融合中的自体移植：随机单盲食品和药物管理局的2年后续随访调查装置豁免研究评论
2. Cervical Disc Replacement: Are We There Yet? Commentary on an article by Michael E-Janssen, DO, et al.: "ProDisc-C Total Disc Replacement Versus Anterior Cervical Discectomy and Fusion for Single-Level Symptomatic Cervical Disc Disease. Seven-Year Follow-up of the Prospective Randomized US Food and Drug Administration Investigational Device Exemption Study" [J] . Mendoza-Lattes Sergio The Journal of Bone and Joint Surgery. American Volume . 2015 ,第21期

机译：颈椎间盘置换术：我们还在那里吗？对Michael E-Janssen，DO等人的一篇文章的评论：“ ProDisc-C全椎间盘置换术与颈前路椎间盘切除术和融合治疗单水平症状性颈椎间盘疾病。美国随机抽样食品的七年随访和药物管理局的研究器械豁免研究”
3. ProDisc-C Total Disc Replacement Versus Anterior Cervical Discectomy and Fusion for Single-Level Symptomatic Cervical Disc Disease Seven-Year Follow-up of the Prospective Randomized US Food and Drug Administration Investigational Device Exemption Study [J] . Janssen Michael E., Zigler Jack E., Spivak Jeffrey M., The Journal of Bone and Joint Surgery. American Volume . 2015 ,第21期

机译：ProDisc-C全椎间盘置换术与颈前路椎间盘切除术和融合治疗单水平症状性颈椎间盘疾病美国食品和药物管理局随机调查性器械免除研究的七年随访
4. Results at 24 months from the prospective randomized multicenter Investigational Device Exemption trial of ProDisc-C versus anterior cervical discectomy and fusion with 4-year follow-up and continued access patients [O] . Rick B. Delamarter, Daniel Murrey, Michael E. Janssen, 2010

机译：ProDisc-C与前路颈椎间盘摘除术以及融合治疗及4年随访和持续接触患者的前瞻性随机多中心研究设备豁免试验在24个月时得出的结果
5. Long-Term Efficacy and Safety of Anterior Cervical Discectomy and Fusion in Single-Level Cervical Disk Disease: 7 Years Follow-up of Food and Drug Administration Investigational Exemption ProDisc-C Study [O] . M. Janssen, B. Kopjar, J. E. Zigler, 2014

机译：单级宫颈椎间盘疾病的长期疗效和安全性和融合单级宫颈椎间盘病：7年的食品和药物管理局调查豁免Prodisc-C研究

i-Factor (TM) Bone Graft vs Autograft in Anterior Cervical Discectomy and Fusion: 2-Year Follow-up of the Randomized Single-Blinded Food and Drug Administration Investigational Device Exemption Study COMMENT

著录项

相似文献

相关主题

期刊订阅